Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Status:
Not yet recruiting
Trial end date:
2026-07-31
Target enrollment:
Participant gender:
Summary
The goal of the CRETE Studies is to investigate the newly identified age-dependent
heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous
catheter-associated deep venous thrombosis in critically ill children.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Yale University
Collaborators:
BJC HealthCare Children's Healthcare of Atlanta Children's Hospital Colorado Children's Hospital Medical Center, Cincinnati Children's Hospital of Philadelphia Children's of Alabama Golisano Children's Hospital Maria Fareri Children's Hospital Medical College of Wisconsin Nationwide Children's Hospital New York Presbyterian Hospital Penn State University University of Iowa Virginia Commonwealth University